Tumor Immune Response as a Biomarker for Metastasis-Free Survival of Breast Cancer and Immune Checkpoint Inhibition Therapy: A Retrospective Cohort Study.

Background: Breast cancers (BRCs) can be classified into 6 molecular subtypes based on gene expression profiles. Previous research suggests that tumor-infiltrating lymphocytes are associated with metastasis-free survival (MFS) in triple-negative and HER2-overexpressing BRC. Objectives: Our study aim...

Full description

Bibliographic Details

Published in:	Breast Cancer: Basic & Clinical Research Vol. 19; pp. 1 - 14
Main Authors:	Lin, Chung-Wu, Chang, Kai-Ming, Ku, Wen-Hui, Kao, Kuo-Jang
Format:	research tables/charts Journal Article
Published:	Sage Publications Inc. 8/24/2025
Online Access:	View this record in EBSCOhost